Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab.

Alama A, Coco S, Genova C, Rossi G, Fontana V, Tagliamento M, Giovanna Dal Bello M, Rosa A, Boccardo S, Rijavec E, Biello F, Longo L, Cavalieri Z, Bruzzo C, Grossi F.

J Clin Med. 2019 Jul 10;8(7). pii: E1011. doi: 10.3390/jcm8071011.

2.

Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer.

Coco S, Bonfiglio S, Cittaro D, Vanni I, Mora M, Genova C, Dal Bello MG, Boccardo S, Alama A, Rijavec E, Sini C, Rossella V, Barletta G, Biello F, Truini A, Bruzzo C, Gallo M, Lazarevic D, Ballestrero A, Grossi F.

Cancers (Basel). 2019 Mar 28;11(4). pii: E441. doi: 10.3390/cancers11040441.

3.

Tactile exploration of virtual objects for blind and sighted people: the role of beta 1 EEG band in sensory substitution and supramodal mental mapping.

Campus C, Brayda L, De Carli F, Chellali R, Famà F, Bruzzo C, Lucagrossi L, Rodriguez G.

J Neurophysiol. 2012 May;107(10):2713-29. doi: 10.1152/jn.00624.2011. Epub 2012 Feb 15.

4.

Inhibition of the nicotinic acetylcholine receptors by cobra venom α-neurotoxins: is there a perspective in lung cancer treatment?

Alama A, Bruzzo C, Cavalieri Z, Forlani A, Utkin Y, Casciano I, Romani M.

PLoS One. 2011;6(6):e20695. doi: 10.1371/journal.pone.0020695. Epub 2011 Jun 13.

5.

Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation.

Paleari L, Catassi A, Ciarlo M, Cavalieri Z, Bruzzo C, Servent D, Cesario A, Chessa L, Cilli M, Piccardi F, Granone P, Russo P.

Cell Prolif. 2008 Dec;41(6):936-59. doi: 10.1111/j.1365-2184.2008.00566.x. Erratum in: Cell Prolif. 2009 Aug;42(4):568. Cell Prolif. 2009 Feb;42(1):122.

PMID:
19040571
6.

In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo.

Alama A, Viale M, Cilli M, Bruzzo C, Novelli F, Tasso B, Sparatore F.

Invest New Drugs. 2009 Apr;27(2):124-30. doi: 10.1007/s10637-008-9148-x. Epub 2008 Jun 19.

PMID:
18563295
7.

Significance of cyclin D1 expression in meningiomas: a preliminary study.

Alama A, Barbieri F, Spaziante R, Bruzzo C, Dadati P, Dorcaratto A, Ravetti JL.

J Clin Neurosci. 2007 Apr;14(4):355-8. Epub 2007 Jan 19.

PMID:
17240151
8.

Characterization of apoptosis induced by marine natural products in non small cell lung cancer A549 cells.

Catassi A, Cesario A, Arzani D, Menichini P, Alama A, Bruzzo C, Imperatori A, Rotolo N, Granone P, Russo P.

Cell Mol Life Sci. 2006 Oct;63(19-20):2377-86.

PMID:
17006627
9.

Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.

Barbieri F, Lorenzi P, Ragni N, Schettini G, Bruzzo C, Pedullà F, Alama A.

Oncology. 2004;66(4):310-5.

PMID:
15218299
10.

Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells.

Barbieri F, Alama A, Tasso B, Boido V, Bruzzo C, Sparatore F.

Invest New Drugs. 2003 Nov;21(4):413-20.

PMID:
14586208
11.

Novel sigma binding site ligands as inhibitors of cell proliferation in breast cancer.

Barbieri F, Sparatore A, Alama A, Novelli F, Bruzzo C, Sparatore F.

Oncol Res. 2003;13(11):455-61.

PMID:
12812359
12.

Chemosensitivity of glioblastoma cells during treatment with the organo-tin compound triethyltin(IV)lupinylsulfide hydrochloride.

Barbieri F, Sparatore F, Bonavia R, Bruzzo C, Schettini G, Alama A.

J Neurooncol. 2002 Nov;60(2):109-16.

PMID:
12635657
13.

Antitumor activity of a new orally active organotin compound: a preliminary study in murine tumor models.

Barbieri F, Viale M, Sparatore F, Schettini G, Favre A, Bruzzo C, Novelli F, Alama A.

Anticancer Drugs. 2002 Jul;13(6):599-604.

PMID:
12172505
14.

Unsymmetrical methylene derivatives of indoles as antiproliferative agents.

Mazzei M, Miele M, Nieddu E, Barbieri F, Bruzzo C, Alama A.

Eur J Med Chem. 2001 Nov-Dec;36(11-12):915-23.

PMID:
11755234
15.

Antiproliferative activity and interactions with cell-cycle related proteins of the organotin compound triethyltin(IV)lupinylsulfide hydrochloride.

Barbieri F, Sparatore F, Cagnoli M, Bruzzo C, Novelli F, Alama A.

Chem Biol Interact. 2001 Mar 14;134(1):27-39.

PMID:
11248220
16.

Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound.

Barbieri F, Viale M, Sparatore F, Favre A, Cagnoli M, Bruzzo C, Novelli F, Alama A.

Anticancer Res. 2000 Mar-Apr;20(2A):977-80.

PMID:
10810384
17.

Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors.

Barbieri F, Cagnoli M, Ragni N, Foglia G, Bruzzo C, Pedullà F, Alama A.

Clin Cancer Res. 1999 Jul;5(7):1837-42.

18.

Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines.

Cagnoli M, Barbieri F, Bruzzo C, Alama A.

Gynecol Oncol. 1998 Sep;70(3):372-7.

PMID:
9790790
19.

Synthesis and biological activity of gold and tin compounds in ovarian cancer cells.

Cagnoli M, Alama A, Barbieri F, Novelli F, Bruzzo C, Sparatore F.

Anticancer Drugs. 1998 Aug;9(7):603-10.

PMID:
9773804
20.

HPLC determination of azidothymidine (AZT) and its metabolite in human plasma.

Mazzei M, Balbi A, Sottofattori E, Bruzzo C, Palamone G, Nicolin A.

Farmaco. 1990 Jun;45(6 Suppl):737-43.

PMID:
2400523

Supplemental Content

Loading ...
Support Center